IFP Advisors, Inc - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 98 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 1.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2021$115,000
+40.2%
3,2580.0%0.00%
-33.3%
Q4 2020$82,000
-33.3%
3,2580.0%0.00%
-57.1%
Q3 2020$123,000
-9.6%
3,2580.0%0.01%
-36.4%
Q2 2020$136,000
+103.0%
3,2580.0%0.01%
+57.1%
Q1 2020$67,000
-23.0%
3,2580.0%0.01%0.0%
Q4 2019$87,000
-2.2%
3,2580.0%0.01%
+16.7%
Q3 2019$89,000
-22.6%
3,258
-19.2%
0.01%
-62.5%
Q1 2019$115,0000.0%4,0330.0%0.02%0.0%
Q1 2016$115,0004,0330.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders